55 related articles for article (PubMed ID: 38748071)
1. Differential Gene Analysis of Langerhans Cell Histiocytosis and the Significance of MMP1-Targeted Drug Repositioning.
Feng X; Yuan X; Hua YY; Tao J; Zhang N
Mol Biotechnol; 2024 May; ():. PubMed ID: 38748071
[TBL] [Abstract][Full Text] [Related]
2. Detection of Immune Microenvironment Changes and Immune-Related Regulators in Langerhans Cell Histiocytosis Bone Metastasis.
Lin J; Tang H; Xu Z; Zeng R
Biomed Res Int; 2023; 2023():1447435. PubMed ID: 36714021
[TBL] [Abstract][Full Text] [Related]
3. Clinical and prognostic characteristics of 95 cases of Langerhans cell histiocytosis in children: a single-institute experience from 2013 to 2020.
Tang X; Gao J; Ma ZG; Guo X; Li Q; Wan Z; Sun JJ
Ann Med; 2021 Dec; 53(1):1537-1546. PubMed ID: 34459688
[TBL] [Abstract][Full Text] [Related]
4. Somatic ARAF mutations in pediatric Langerhans cell histiocytosis: clinicopathologic, genetic and functional profiling.
Liu R; Guo Y; Han L; Feng S; Cao J; Sun Y; Cao Z; Cui X
Clin Exp Med; 2023 Dec; 23(8):5269-5279. PubMed ID: 37572153
[TBL] [Abstract][Full Text] [Related]
5. Identification of Effective Diagnostic Biomarkers and Immune Cell Infiltration in Atopic Dermatitis by Comprehensive Bioinformatics Analysis.
Li C; Lu Y; Han X
Front Mol Biosci; 2022; 9():917077. PubMed ID: 35911963
[No Abstract] [Full Text] [Related]
6. Epigenomics and Single-Cell Sequencing Define a Developmental Hierarchy in Langerhans Cell Histiocytosis.
Halbritter F; Farlik M; Schwentner R; Jug G; Fortelny N; Schnöller T; Pisa H; Schuster LC; Reinprecht A; Czech T; Gojo J; Holter W; Minkov M; Bauer WM; Simonitsch-Klupp I; Bock C; Hutter C
Cancer Discov; 2019 Oct; 9(10):1406-1421. PubMed ID: 31345789
[TBL] [Abstract][Full Text] [Related]
7. The extracellular matrix as hallmark of cancer and metastasis: From biomechanics to therapeutic targets.
Sleeboom JJF; van Tienderen GS; Schenke-Layland K; van der Laan LJW; Khalil AA; Verstegen MMA
Sci Transl Med; 2024 Jan; 16(728):eadg3840. PubMed ID: 38170791
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA Regulatory Network Analysis Using miRNet 2.0.
Chang L; Xia J
Methods Mol Biol; 2023; 2594():185-204. PubMed ID: 36264497
[TBL] [Abstract][Full Text] [Related]
9. Targeting MAPK/NF-κB Pathways in Anti-Inflammatory Potential of Rutaecarpine: Impact on Src/FAK-Mediated Macrophage Migration.
Jayakumar T; Lin KC; Chang CC; Hsia CW; Manubolu M; Huang WC; Sheu JR; Hsia CH
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008520
[TBL] [Abstract][Full Text] [Related]
10. Treatment outcomes and prognostic factors of patients with adult Langerhans cell histiocytosis.
Cao XX; Duan MH; Zhao AL; Cai H; Chen J; Gao XM; Liu T; Cai HC; Zhang L; Sun J; Liang ZY; Zhou DB; Li J
Am J Hematol; 2022 Feb; 97(2):203-208. PubMed ID: 34797941
[TBL] [Abstract][Full Text] [Related]
11. Histiocytic disorders.
McClain KL; Bigenwald C; Collin M; Haroche J; Marsh RA; Merad M; Picarsic J; Ribeiro KB; Allen CE
Nat Rev Dis Primers; 2021 Oct; 7(1):73. PubMed ID: 34620874
[TBL] [Abstract][Full Text] [Related]
12. The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases.
Cabral-Pacheco GA; Garza-Veloz I; Castruita-De la Rosa C; Ramirez-Acuña JM; Perez-Romero BA; Guerrero-Rodriguez JF; Martinez-Avila N; Martinez-Fierro ML
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33419373
[TBL] [Abstract][Full Text] [Related]
13. Screening novel drug candidates for Alzheimer's disease by an integrated network and transcriptome analysis.
Peng Y; Yuan M; Xin J; Liu X; Wang J
Bioinformatics; 2020 Nov; 36(17):4626-4632. PubMed ID: 32516365
[TBL] [Abstract][Full Text] [Related]
14. Langerhans cell histiocytosis.
Rodriguez-Galindo C; Allen CE
Blood; 2020 Apr; 135(16):1319-1331. PubMed ID: 32106306
[TBL] [Abstract][Full Text] [Related]
15. g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update).
Raudvere U; Kolberg L; Kuzmin I; Arak T; Adler P; Peterson H; Vilo J
Nucleic Acids Res; 2019 Jul; 47(W1):W191-W198. PubMed ID: 31066453
[TBL] [Abstract][Full Text] [Related]
16. Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study.
Héritier S; Barkaoui MA; Miron J; Thomas C; Moshous D; Lambilliotte A; Mazingue F; Kebaili K; Jeziorski E; Plat G; Aladjidi N; Pacquement H; Galambrun C; Brugières L; Leverger G; Mansuy L; Paillard C; Deville A; Pagnier A; Lutun A; Gillibert-Yvert M; Stephan JL; Cohen-Aubart F; Haroche J; Pellier I; Millot F; Gandemer V; Martin-Duverneuil N; Taly V; Hélias-Rodzewicz Z; Emile JF; Hoang-Xuan K; Idbaih A; Donadieu J
Br J Haematol; 2018 Nov; 183(4):608-617. PubMed ID: 30421536
[TBL] [Abstract][Full Text] [Related]
17. TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions.
Han H; Cho JW; Lee S; Yun A; Kim H; Bae D; Yang S; Kim CY; Lee M; Kim E; Lee S; Kang B; Jeong D; Kim Y; Jeon HN; Jung H; Nam S; Chung M; Kim JH; Lee I
Nucleic Acids Res; 2018 Jan; 46(D1):D380-D386. PubMed ID: 29087512
[TBL] [Abstract][Full Text] [Related]
18. Late outcomes in children with Langerhans cell histiocytosis.
Chow TW; Leung WK; Cheng FWT; Kumta SM; Chu WCW; Lee V; Shing MMK; Li CK
Arch Dis Child; 2017 Sep; 102(9):830-835. PubMed ID: 28442470
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
